HAL
39
-9
HRL
23
-4
PDCO
60
2
ES
34
-2
UAL
50
6
HPE
59
2
EMC
93
4
AAPL
56
-3
D
35
-2
KEY
50
7
STT
40
-8
NFLX
61
-3
CA
32
-4
MCD
54
-5
CMS
61
-3
MRK
41
-9
AVGO
40
3
MET
58
-2
UNH
42
4
PFE
32
2
HAL
39
-9
HRL
23
-4
PDCO
60
2
ES
34
-2
UAL
50
6
HPE
59
2
EMC
93
4
AAPL
56
-3
D
35
-2
KEY
50
7
STT
40
-8
NFLX
61
-3
CA
32
-4
MCD
54
-5
CMS
61
-3
MRK
41
-9
AVGO
40
3
MET
58
-2
UNH
42
4
PFE
32
2
Financhill
Back

Fidelity National Information Services Vs. Viking Therapeutics Industry Stock Comparison

Buy
51

FIS
Fidelity National Information Services

Last Price:
75.32
Seasonality Move:
-2.02%
Sell
47

VKTX
Viking Therapeutics

Last Price:
52.96
Seasonality Move:
1.76%
Buy
51
Fidelity National Information Services (FIS) is a Buy

Is Fidelity National Information Services a Buy, Sell or Hold?

  • The current Fidelity National Information Services [FIS] share price is $75.36. The Score for FIS is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • FIS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
47
Viking Therapeutics (VKTX) is a Sell

Is Viking Therapeutics a Buy, Sell or Hold?

  • The current Viking Therapeutics [VKTX] share price is $52.96. The Score for VKTX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • VKTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FIS Stock Price Chart

What is Fidelity National Information Services's stock price today?

  • The Fidelity National Information Services share price today is $75.36
    The current trend is relatively stagnant and FIS is experiencing buying pressure, which is a positive indicator for future bullish movement.

VKTX Stock Price Chart

What is Viking Therapeutics's stock price today?

  • The Viking Therapeutics share price today is $52.96
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing slight buying pressure.

FIS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.04 Buy
Relative Strength Index (14 RSI): 48.46 Sell
Chaikin Money Flow: 3640788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (75.09 - 76.97) Sell
Bollinger Bands (100): (66.99 - 76.11) Buy

VKTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.9 Sell
Relative Strength Index (14 RSI): 43.41 Sell
Chaikin Money Flow: 113403 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (50.34 - 60.74) Sell
Bollinger Bands (100): (47.23 - 79.29) Sell

FIS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 75.65 Sell
20-day SMA: 76.14 Sell
50-day SMA: 74.52 Buy
200-day SMA: 64.13 Buy
8-day EMA: 75.49 Sell
20-day EMA: 75.76 Sell
50-day EMA: 74.53 Buy
200-day EMA: 67.82 Buy

VKTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 50.6 Buy
20-day SMA: 53.66 Sell
50-day SMA: 63.66 Sell
200-day SMA: 39.18 Buy
8-day EMA: 51.13 Buy
20-day EMA: 54.21 Sell
50-day EMA: 59.37 Sell
200-day EMA: 45.7 Buy

Fidelity National Information Services Earnings Growth & FIS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.32 per share, an increase next quarter of $0.08 per share, an increase this year of $1.62 per share, and an increase next year of $0.54 per share.

Viking Therapeutics Earnings Growth & VKTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.43 per share.

Fidelity National Information Services Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Viking Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):